Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death

JAMA

Volumn 303, Issue 14, 2010, Pages 1401-1409

  Patorno, Elisabetta ^a   Bohn, Rhonda L ^a,b   Wahl, Peter M ^b   Avorn, Jerry ^a   Patrick, Amanda R ^a   Liu, Jun ^a   Schneeweiss, Sebastian ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HEALTHCORE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; FEMALE; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SUICIDE; SUICIDE ATTEMPT; TREATMENT DURATION; TREATMENT OUTCOME; VIOLENCE; VIOLENT DEATH; AGED; CAUSE OF DEATH; MIDDLE AGED; RISK; STATISTICS; UNITED STATES;

ADULT; AGED; ANTICONVULSANTS; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK; SUICIDE; SUICIDE, ATTEMPTED; UNITED STATES; VIOLENCE;

EID: 77950903719     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.410     Document Type: Article

References (45)

1. Ettinger AB, Argoff CE. Use of antiepileptic drugs for nonepileptic conditions. Neurotherapeutics. 2007; 4(1):75-83.
2. JohannessenLandmarkC. Antiepileptic drugs in non-epilepsy disorders. CNS Drugs. 2008;22(1):27-47.
3. Spina E, Perugi G. Antiepileptic drugs. Epileptic Disord. 2004;6(2):57-75.
4. Hamer AM, Haxby DG, McFarland BH, Ketchum K. Gabapentin use in a managed Medicaid population. J Manag Care Pharm. 2002;8(4):266-271.
5. Rosenberg JM, Salzman C. Update: new uses for lithium and anticonvulsants. CNS Spectr. 2007;12(11):831-841. (Pubitemid 350247188)
6. Statistical review and evaluation: antiepileptic drugs and suicidality [May 23, 2008]. http://www.fda.gov /ohrms/dockets/ac/08/briefing/2008-4372b1-01- FDA.pdf. Accessed December 4, 2009.
7. Joint meeting of the Peripheral and Central Nervous Drugs Advisory Committee and the Psychopharmacologic Drugs Advisory Committee: briefing material, July 10, 2008. http://www.fda.gov/ohrms /dockets/ac/08/briefing/2008- 4372b1-00-index.html. Accessed December 4, 2009.
8. FDA Public Health Advisory: suicidal thoughts and behavior anticonvulsant. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformation forPatientsandProviders/ucm100195.htm. Accessed December 4, 2009.
9. Update on suicidal behavior and ideation and anticonvulsant drugs: update May 5, 2009. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm100190.htm. Accessed December 4, 2009.
10. Avorn J. Drug warnings that can cause fits. N Engl J Med. 2008;359(10):991-994.
11. Ray WA. Evaluating medication effects outside of clinical trials. Am J Epidemiol. 2003;158(9):915-920.
12. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: US Dept of Health and Human Services. 1988.
13. Iribarren C, Sidney S, Jacobs DR Jr, Weisner C. Hospitalization for suicide attempt and completed suicide. Soc Psychiatry Psychiatr Epidemiol. 2000;35(7):288-296.
14. Moyer LA, Boyle CA, Pollock DA. Validity of death certificates for injury-related causes of death. Am J Epidemiol. 1989;130(5):1024-1032.
15. Clark DE, DeLorenzo MA, Lucas FL, Wennberg DE. Epidemiology and short-term outcomes of injured Medicare patients. J Am Geriatr Soc. 2004; 52(12):2023-2030. (Pubitemid 41725018)
16. Patrick AR, Miller M, Barber CW, Wang PS, Canning CF, Schneeweiss S. Identifying intentional self-harm hospitalizations when E-codes are incompletely recorded. Pharmacoepidemiol Drug Saf. 2009; 18:S1-S273.
17. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
18. Phillips DP, Ruth TE. Adequacy of official suicide statistics for scientific research and public policy. Suicide Life Threat Behav. 1993;23(4):307-319.
19. Ohberg A, Lonnqvist J. Suicides hidden among undetermined deaths. Acta Psychiatr Scand. 1998; 98(3):214-218.
20. Physicians' Current Procedural Terminology (CPT). 4th ed. Chicago, IL: American Medical Association; 1989.
21. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009; 20(4):512-522.
22. Parsons L. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the 26th Annual SAS Users Group International Conference. SAS Institute Inc, 2001. http://www2.sas.com/ proceedings/sugi26/p214-26.pdf. Accessed March 22, 2010.
23. Austin PC, Lee DS. The concept of the marginally matched subject in propensity-score matched analyses. Pharmacoepidemiol Drug Saf. 2009; 18(6):469-482.
24. RothmanKJ.Noadjustments areneededfor multiple comparisons. Epidemiology. 1990;1(1):43-46.
25. Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLoS Med. 2008;5(3):e67.
26. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003; 290(11):1467-1473. (Pubitemid 37430401)
27. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. J Affect Disord. 2007; 103(1-3):5-11.
28. Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord. 2008;107(1-3):23-28.
29. Schmitz B. Effects of antiepileptic drugs on mood and behavior. Epilepsia. 2006;47(suppl 2):28-33. (Pubitemid 44684616)
30. Reijs R, Aldenkamp AP, De Krom M. Mood effects of antiepileptic drugs. Epilepsy Behav. 2004; 5(suppl 1):S66-S76.
31. Ettinger AB. Psychotropic effects of antiepileptic drugs. Neurology. 2006;67(11):1916-1925.
32. Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007;30(7):555-567. (Pubitemid 47037315)
33. Barabas G, Matthews WS. Barbiturate anticonvulsants as a cause of severe depression. Pediatrics. 1988;82(2):284-285.
34. Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology. 1999;53(5)(suppl 2):53-67.
35. Kalinin VV. Suicidality and antiepileptic drugs: is there a link? Drug Saf. 2007;30(2):123-142.
36. Wolf SM, Shinnar S, Kang H, Gil KB, Moshé SL. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia. 1995;36(12):1203-1205.
37. Lee DO, Steingard RJ, Cesena M, Helmers SL, Riviello JJ, Mikati MA. Behavioral side effects of gabapentin in children. Epilepsia. 1996;37(1):87-90. (Pubitemid 26021582)
38. Tallian KB, Nahata MC, Lo W, Tsao CY. Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia. 1996;37(5): 501-502. (Pubitemid 26140607)
39. Beran RG, Gibson RJ. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia. 1998;39(3):280-282.
40. Ettinger AB, Weisbrot DM, Saracco J, Dhoon A, Kanner A, Devinsky O. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia. 1998;39(8):874-877. (Pubitemid 28368150)
41. Pereira J, Marson AG, Hutton JL. Tiagabine add-on for drug resistant partial epilepsy. Cochrane Database Syst Rev. 2002;3(3):CD001908.
42. Grabowska-Grzyb A, Jedrzejczak J, Naganska E, Fiszer U. Risk factors for depression in patients with epilepsy. Epilepsy Behav. 2006;8(2):411-417. (Pubitemid 43231234)
43. Curran HV, Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol. 1993;44(6):529-533. (Pubitemid 23197836)
44. French JA, Pedley TA. Clinical practice: initial management of epilepsy. N Engl J Med. 2008;359 (2):166-176.
45. Elger CE, Schmidt D. Modern management of epilepsy: a practical approach. Epilepsy Behav. 2008; 12(4):501-539.